Organisation paid for research Program year 2025 Source: CMS Open Payments

Vantage EyeCare, LLC

Neither a doctor nor a teaching hospital

Research payments

$96,632

32 payments

Through program year 2025, Vantage EyeCare, LLC is reported as receiving $96,632 in research payments, across 32 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$600	1
2024	Research	$628	2
2023	Research	$5,860	3
2022	Research	$7,440	2
2021	Research	$8,200	4
2020	Research	$40,911	11
2019	Research	$32,994	9

Breakdown

Who paid Research payments · program years 2019–2025

Glaukos Corporation $96,632 32 payments

Studies the money was for Research payments · program years 2019–2025

A Prospective, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass System, Model iS3, in Subjects with Refractory Glaucoma $32,994 9 payments
A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus $32,375 3 payments
A Phase IV Observational Registry to Assess the Safety and Durability of Effect of Corneal Collagen Cross-linking With Photrexa Viscous, Photrexa, and the KXL System in Patients With Corneal Ectasia Following Refractive Surgery $7,685 6 payments
Observational Registry to Assess the Durability of Effect of Corneal Colagen Cross-linking $5,860 3 payments
Observational Registry to Assess the Durability of Effect of Corneal Colagen Cross-linking $5,303 5 payments
A Prospective, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass System, Model iS3, in Subjects with Refractory Glaucoma $4,976 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.